Bal Pharma’s Lifezen Healthcare enters into agreement with Bennett Coleman & Company

20 Mar 2015 Evaluate

Bal Pharma’s promoted Lifezen Healthcare has entered into an Investment agreement with Bennett Coleman & Company. The company is promoter of Lifezen Healthcare which was incorporated with proposed objects of carrying on the business of manufacturing, marketing, distributing, selling and trading of pharma products.

Bennett, Coleman & Company has envisaged its interest in investing in fully convertible debentures of Lifezen Healthcare to the extent of Rs 20 crore and the company is the cosignatory to the said convertible debenture subscription agreement, as the promoter of Lifezen Healthcare.

Bal Pharma is in the business interest in area of manufacturing API, finished formulations, ayurvedic and research and development. It is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.


Bal Pharma Share Price

107.02 0.47 (0.44%)
16-Apr-2025 12:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.25
Dr. Reddys Lab 1150.50
Cipla 1495.60
Lupin 1985.90
Zydus Lifesciences 872.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...